在患有COVID-19感染的患者中致命的系统毛细血管泄漏综合征
Hiroaki Kawano1, Masataka Umeda2, Tomohiro Honda1
1Department of Cardiovascular Medicine, Nagasaki University Graduate School of Biomedical Sciences, Japan.
Internal medicine (Tokyo, Japan)
|April 24, 2024
概括
与2019年冠状病毒病 (COVID-19) 相关的全身毛细血管泄漏综合征 (SCLS) 可以迅速导致严重疾病. 这一病例突显了COVID-19引起的SCLS致命的呈现,导致震惊和多器官衰竭.
科学领域:
- 关键护理医学 关键护理医学
- 传染性疾病 传染性疾病
- 心脏病学 心脏病学
背景情况:
- 系统毛细血管泄漏综合征 (SCLS) 是一种罕见的疾病,其特点是经常出现低血压,血度和低albuminemia.
- 冠状病毒疾病2019 (COVID-19) 与广泛的临床表现有关,包括心血管并发症.
研究的目的:
- 报告与COVID-19相关的SCLS罕见且致命的病例.
- 为了强调这种情况的快速进展和严重后果.
主要方法:
- 一个29岁的日本妇女的案例报告.
- 记录了临床表现,实验室发现,诊断工作 (冠状动脉动图) 和干预措施 (体外膜氧化,Impella CP,无otropic剂).
主要成果:
- 患者出现了发烧,心脏性休克,心脏骤停,多器官衰竭,血液度,低蛋白血症和心肌损伤.
- 尽管进行了包括机械循环支持在内的积极管理,但该患者经历了渐进性的低血压休克,严重贫血,并在入院18小时后死亡.
- 发性心肌炎最初被怀疑是由于正常的冠状动脉血管造影和心肌损伤.
结论:
- 这一案例强调了COVID-19引发SCLS的潜力,导致迅速致命的结果.
- 在COVID-19的背景下,早期识别和管理SCLS至关重要,尽管严重表现的治疗选择仍然有限.
相关概念视频
Acute Respiratory Failure-III
184
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
184
Pneumothorax-I
201
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
201
Pleural Effusion I: Introduction
933
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
933
Pneumonia I: Introduction
226
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
226
Pneumonia II: Pathophysiology
261
The pathophysiology of pneumonia involves the following steps:
261
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K


